高级检索
当前位置: 首页 > 详情页

A standardized pathological proposal for evaluating microvascular invasion of hepatocellular carcinoma: a multicenter study by LCPGC

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Pathol, 225 Changhai Rd, Shanghai 200438, Peoples R China [2]Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai, Peoples R China [3]Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Pathol, Hangzhou, Peoples R China [4]Sichuan Univ, West China Hosp, Dept Pathol, Chengdu, Peoples R China [5]Sun Yat Sen Univ, Dept Pathol, Canc Ctr, Guangzhou, Peoples R China [6]Fujian Med Univ, Mengchao Hepatobiliary Hosp, Dept Pathol, Fuzhou, Peoples R China [7]Tianjin Med Univ Canc Inst & Hosp, Dept Pathol, Tianjin, Peoples R China [8]PLA, Hosp Joint Logist Support Force 900, Dept Pathol, Fuzhou, Peoples R China [9]Southwest Hosp, Inst Pathol, Chongqing, Peoples R China [10]Southwest Hosp, Southwest Canc Ctr, Chongqing, Peoples R China [11]Shandong First Med Univ, Affiliated Hosp 1, Dept Pathol, Jinan, Peoples R China [12]Guangxi Med Univ, Affiliated Tumor Hosp, Dept Pathol, Nanning, Peoples R China [13]Zhengzhou Univ, Affiliated Hosp 1, Dept Pathol, Zhengzhou, Peoples R China [14]Guangzhou First Peoples Hosp, Dept Pathol, Guangzhou, Peoples R China [15]Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou, Peoples R China [16]Peoples Liberat Army, Gen Hosp, Dept Pathol, Beijing, Peoples R China [17]Cent South Univ, Xiangya Hosp, Dept Pathol, Changsha, Peoples R China [18]Peking Univ Canc Hosp & Inst, Dept Pathol, Beijing, Peoples R China [19]First Hosp China Med Univ, Dept Pathol, Shenyang, Peoples R China [20]Fudan Univ, Shanghai Canc Ctr, Dept Pathol, 270 Dong An Rd, Shanghai 200032, Peoples R China [21]Fourth Mil Med Univ, Xijing Hosp, Dept Pathol, Xian, Peoples R China [22]Nanjing Drum Tower Hosp, Dept Pathol, Nanjing, Peoples R China [23]Changzheng Hosp, Dept Pathol, Shanghai, Peoples R China [24]Nantong Univ, Affiliated Canc Hosp, Dept Pathol, Nantong, Peoples R China [25]Univ Sci & Technol China, Affiliated Hosp 1, Dept Pathol, Hefei, Peoples R China [26]Shanxi Canc Hosp, Dept Pathol, Taiyuan, Peoples R China [27]Harbin Med Univ, Canc Hosp, Dept Pathol, Harbin, Peoples R China [28]Xiamen Univ, Zhongshan Hosp, Dept Pathol, Xiamen, Peoples R China [29]Huazhong Univ Sci & Technol,Tongji Hosp,Inst Pathol,Wuhan,Peoples R China [30]Second Hosp Anhui Med Univ, Dept Pathol, Hefei, Peoples R China [31]Dalian Med Univ, Affiliated Hosp 1, Dept Pathol, Dalian, Peoples R China [32]Xuzhou Canc Hosp, Dept Pathol, Xuzhou, Jiangsu, Peoples R China [33]Genome Wisdom Inst, 67 North Fourth Ring West Rd, Beijing 100800, Peoples R China
出处:
ISSN:

关键词: Hepatocellular carcinoma Sampling Microvascular invasion Grading Recurrence Prognosis

摘要:
Background and aims Microvascular invasion (MVI) is a key pathological factor that severely affects the postoperative prognosis of patients with hepatocellular carcinoma (HCC). However, no MVI classification schemes based on standardized gross sampling protocols of HCC are available at present. Methods 119 HCC specimens were sampled at multiple sites (3-, 7-, and 13 points) for the optimum MVI detection rate. 16,144 resected HCCs were graded as M0, M1 or M2 by adopting three-tiered MVI grading (MVI-TTG) scheme based on the seven-point sampling protocol (SPSP). Survival analyses were performed on 2573 patients to explore the advantages of MVI-TTG. Results The MVI detection rate determined by SPSP was significantly higher than that determined by the 3-point sampling method (34.5% vs. 47.1%, p = 0.048), but was similar to that determined by the 13-point sampling method (47.1% vs. 51.3%, p = 0.517). Among 16,144 resected HCCs, the proportions of M0, M1 and M2 specimens according to SPSP were 53.4%, 26.2% and 20.4%, respectively. Postoperative survival analysis in 2573 HCC patients showed that the 3-year recurrence rates in M0, M1 and M2 MVI groups were 62.5%, 71.6% and 86.1%, respectively (p < 0.001), and the corresponding 3-year overall survival (OS) rates were 94.1%, 87.5% and 67.0%, respectively (p < 0.001). M1 grade was associated with early recurrence, while M2 grade was associated with both early and late recurrence. MVI-TTG had a larger area under the curve and net benefit rate than the two-tiered MVI grading scheme for predicting time to recurrence and OS. Conclusions SPSP is a practical method to balance the efficacy of sampling numbers and MVI detection rates. MVI-TTG based on SPSP is a better prognostic predictor than the two-tiered MVI scheme. The combined use of SPSP and MVI-TTG is recommended for the routine pathological diagnosis of HCC.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 2 区 医学
小类 | 3 区 胃肠肝病学
最新[2025]版:
大类 | 1 区 医学
小类 | 2 区 胃肠肝病学
JCR分区:
出版当年[2018]版:
Q1 GASTROENTEROLOGY & HEPATOLOGY
最新[2023]版:
Q1 GASTROENTEROLOGY & HEPATOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者单位: [1]Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Pathol, 225 Changhai Rd, Shanghai 200438, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:426 今日访问量:0 总访问量:408 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)